0
0
A comprehensive review published January 16, 2026, in The Lancet Obstetrics, Gynaecology & Women’s Health concludes that paracetamol (acetaminophen, sold as Tylenol) use during pregnancy does not increase risks of autism, ADHD, or intellectual disabilities in children. This “gold-standard” analysis, prompted by U.S. President Donald Trump’s 2025 warnings, examined 43 studies and prioritized high-quality evidence like sibling comparisons. European researchers led by Professor Asma Khalil from St George’s University of London aimed to address public confusion and restore confidence in this common painkiller.
Research Background and Trump’s Role
President Trump, alongside Health Secretary Robert F. Kennedy Jr., claimed in September 2025 that paracetamol during pregnancy links to autism, advising pregnant women to “fight like hell” to avoid it except for severe fever. These statements, made during a press conference, echoed earlier observational studies suggesting weak associations but ignored confounding factors like genetics or maternal health. Medical bodies like ACOG and WHO quickly rebutted, warning that avoiding paracetamol could harm mothers by leaving pain or fever untreated, risking miscarriage or preeclampsia.
Prior research fueled debate: A 2024 Swedish study of 2.48 million children found no risk in sibling analyses (hazard ratio for autism: 0.98), attributing apparent links to familial confounding. Meta-analyses without sibling controls showed small odds increases (e.g., 19-21% for autism/ADHD symptoms), but smaller cohorts drove results, and biases like recall error persisted.
Key Findings from the Landmark Review
The new systematic review and meta-analysis synthesized 43 studies, focusing on low-bias designs, sibling comparisons, and long-term follow-up (at least 5 years). It found no causal association across autism spectrum disorder, ADHD, or intellectual disability, even with prolonged exposure. Sibling studies, which control for shared genetics and environment, were decisive: A Japanese cohort initially suggested minor risks, but adjustments for confounding eliminated them.
Statistical rigor stood out. One included analysis of nearly 186,000 exposed Swedish children (1995-2019) confirmed no elevated autistic traits. Overall, weaker studies showing associations were excluded, as they failed to adjust for differences like pre-existing maternal conditions. Lead author Asma Khalil stated: “Paracetamol is safe for use during pregnancy… The main takeaway is reassurance: When utilized as directed, the best available evidence does not indicate a causal relationship.”
Expert Commentary and Endorsements
Independent specialists praised the methodology. Professor Ian Douglas from the London School of Hygiene & Tropical Medicine highlighted exclusion of low-quality studies. Professor Jan Haavik from the University of Bergen called it “strong evidence” that “should effectively put this question to rest.” Dr. Monique Botha from Durham University noted: “When this higher-quality evidence is examined, the findings are clear: there is no evidence.”
Major organizations align. ACOG affirms acetaminophen as the “safest first-line analgesic and antipyretic,” essential for managing fever or preeclampsia headaches. RCOG, FIGO, EMA, and MHRA recommend it when clinically needed, at lowest effective dose for shortest duration. Steven J. Fleischman, MD, ACOG president, warned against “irresponsible” claims confusing patients.
Autism experts emphasize multifactorial causes—genetics interplay with environment—not single agents like paracetamol. Kenvue (Tylenol maker) opposed Trump’s views, citing independent research.
Public Health Implications
Paracetamol remains vital: Up to 65% of pregnant women use it for pain, fever, or headaches. Untreated fever raises miscarriage or birth defect risks; alternatives like ibuprofen pose greater concerns in later pregnancy. This review reassures healthcare providers and patients, potentially reducing anxiety-driven avoidance.
For consumers, use as directed: 500-1000mg every 4-6 hours, max 4g/day, short-term. Discuss with doctors for personalized advice, especially with conditions like liver issues. Globally, autism affects ~1-2% of children, ADHD ~5%; no evidence ties it to this safe option.
Limitations and Balanced View
No study is perfect. Observational data can’t fully prove causality, though sibling designs minimize bias. Some excluded studies suggested associations from prolonged use (≥28 days), possibly reflecting underlying issues. The review notes evolving evidence; long-term impacts need monitoring.
Conflicting 2021 consensus urged precaution, but faced criticism for overstating risks. Trump’s claims amplified unproven links, drawing backlash from autistic individuals feeling blamed. Objectivity prevails: Autism’s genetic roots dominate; paracetamol’s benefits outweigh theoretical harms.
(Word count: 1,048)
References
- https://www.reuters.com/business/healthcare-pharmaceuticals/paracetamoltylenol-pregnancy-is-safe-says-research-prompted-by-trump-autism-2026-01-16/
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
